…uszko R, Sugawara S, et al. Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the phase III IMpower133 study and…
All extracted diseases
Showing 1,081–1,140 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
Articles mentioning diseases
23,712 articles · page 554 of 1976…tion therapy.Conclusions The incidence and severity of irAEs in NSCLC patients treated with nivolumab was consistent with safety prof…
…d to non-hispanics, improved survival in Hispanic patients with CPA disease treated first line was seen (mOS 29 months vs 16 months…
…andard of care for newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC). The addition of radiation (RT) to the primary prostate…
…Background Glioblastoma (GBM), the most common malignant primary brain tumor, remains i…
…Background HPV-associated malignancies are a major health concern, with >630,000 cases occurring annua…
…tomig, an anti-PD-1/ TIGIT bispecific, for CPI-naïve metastatic NSCLC with PD-L1 1-49% or ≥50%. J Thorac Oncol. 2024;19:10,S33.…
…g has demonstrated encouraging results in a Phase I/II trial of non-small cell lung cancer (NSCLC) ( NCT04995523), and is currently being evaluated in mul…
…A 57-year-old male was diagnosed with moderately differentiated CRC (pT3pN1(3/12)-M0, stage IIIB) and underwent left hemicolectomy …
…r decades into a frontline treatment for multiple malignancies. Colorectal cancer (CRC), an early-onset and high-mortality cancer type, demonstra…
…Background A significant proportion of treatment-naive lung adenocarcinoma (LUAD) patients exhibit intrinsic resistance to neoadjuvant che…
…ciates with an immune activated ‘hot’ tumor microenvironment.In melanoma, elevated baseline activated CD8+ central memory T cells and pr…